Chicken skin mucosa surrounding adult colorectal adenomas is a risk factor for carcinogenesis

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 35, Issue 6, 2012, Pages 527-532

  Guan, JingMing ^a   Zhao, RuiBo ^a   Zhang, XueYan ^a   Cheng, YanQiu ^a   Guo, YuDong ^b   Wang, LiYan ^a   Mi, LiNa ^a   Liu, Fei ^a   Ma, Xiao ^a   Li, Bao Jie ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Department of Urological Surgery   (China)

Author keywords

apoptosis; carcinogenesis; cell proliferation; chicken skin mucosa; colorectal adenoma

Indexed keywords

CASPASE 3; CYCLOOXYGENASE 2; KI 67 ANTIGEN; SURVIVIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER RISK; CANCER TISSUE; CELL PROLIFERATION; CHICKEN; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL ADENOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PROTEIN EXPRESSION; RISK ASSESSMENT; SKIN;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; APOPTOSIS; CASPASE 3; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; COLONIC POLYPS; CYCLOOXYGENASE 2; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INTESTINAL MUCOSA; KI-67 ANTIGEN; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84870244734     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31821dedf7     Document Type: Article

References (36)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.
2. Morson BC. The evolution of colorectal carcinoma. Clin Radiol. 1984;35:425-431. (Pubitemid 15210532)
3. Ying S. The progress of clinical research of colorectal cancer. New theories and new technologies of oncology. 1997:782-802. Shanghai Science and Technology Education Press.
4. Shatz BA, Weinstock LB, Thyssen EP, et al. Colonic chicken skin mucosa: An endoscopic and histological abnormality adjacent to colonic neoplasms. Am J Gastroenterol. 1998;93:623-627. (Pubitemid 29081015)
5. Guo J, Wang H, Wang Y. Clinical and pathological analysis of indicators of colorectal adenoma. Shiyong Zhongliuxue Zazhi. 2000;14:2.
6. Liu S, Wang J. Endoscopic diagnosis and pathological analysis of colorectal polyps. Guangsong Yixueyuanbao. 2003;21:3.
7. Nowicki MJ, Bishop PR, Subramony C, et al. Colonic chickenskin mucosa in children with polyps is not a preneoplastic lesion. J Pediatr Gastroenterol Nutr. 2005;41:600-606. (Pubitemid 41579669)
8. Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA): Quantitative assay for immunoglobulin G. Immunochemistry. 1977;8:4.
9. Van Weeman BK, Schuurs AH. Immunoassay using antigenenzyme conjugates. FEBS Lett. 1971;15:5.
10. Li L, Jian K, Zhang S, et al. Statistical analysis of cancer incidence and mortality registration data from 12 cities and counties in China during 1993 and 1997. Bull Chin Can. 2002;11:11.
11. Whittemore AS, Wu-Williams AH, Lee M, et al. Diet, physical activity, and colorectal cancer among Chinese in North America and China. J Natl Cancer Inst. 1990;82:915-926. (Pubitemid 20176559)
12. Zheng S, Zhou L, Yu H. Case-control study of colorectal cancer in six regions of China. Zhongliu. 1995;15:4.
13. Chen K, Qiu JL, Zhang Y. Meta-analysis study on risk factors of colorectal cancer. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2002;31:254-258.
14. Jia D, Shen G, She Y, et al. Colorectal cancer case-control studies. Zhnghua Liuxingbingxue Zazhi. 1985;5:4.
15. Evan G, Littlewood T. A matter of life and cell death. Science. 1998;281:1317-1322. (Pubitemid 28406818)
16. Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol. 1990;1:199-206.
17. Saleh HA, Jackson H, Banerjee M. Immunohistochemical expression of bcl-2 and p53 oncoproteins: Correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia. Appl Immunohistochem Mol Morphol. 2000;8:175-182.
18. Guzinska-Ustymowicz K, Pryczynicz A, Kemona A, et al. Correlation between proliferation markers: pcna, Ki-67, MCM-and antiapoptotic protein Bcl-2 in colorectal cancer. Anticancer Res. 2009;29:3049-3052.
19. Radovanovic-Dinic B, Nagorni A, Katic V, et al. An immunohistochemical study of Ki-67 in colorectal adenoma. Med Arh. 2009;63:16-18.
20. Nabi U, Nagi AH, Sami W. Ki-67 proliferating index and histological grade, type and stage of colorectal carcinoma. J Ayub Med Coll Abbottabad. 2008;20:44-48.
21. Sheng H, Shao J, Washington MK, et al. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem. 2001;276:18075-18081.
22. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA. 1997;94:3336-3340. (Pubitemid 27157312)
23. Doherty GA, Byrne SM, Austin SC, et al. Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer. Br J Cancer. 2009;101:483-491.
24. Wu KK, Liou JY. Cyclooxygenase inhibitors induce colon cancer cell apoptosis Via PPARdelta->14-3-3epsilon pathway. Methods Mol Biol. 2009;512:295-307.
25. Depraetere V, Golstein P. Dismantling in cell death: Molecular mechanisms and relationship to caspase activation. Scand J Immunol. 1998;47:523-531. (Pubitemid 28273361)
26. Tan H, Liu J, Wu S. Survivin expression and its significance in colorectal cancer. Zhonghua Shiyan Waike Zazhi. 2005;22:3.
27. Tan HY, Liu J, Wu SM, et al. Expression of a novel apoptosis inhibitor-survivin in colorectal carcinoma. World J Gastroenterol. 2005;11:4689-4692. (Pubitemid 41179524)
28. Shin S, Sung BJ, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry. 2001;40:1117-1123. (Pubitemid 32108606)
29. Chen WC, Liu Q, Fu JX, et al. Expression of survivin and its significance in colorectal cancer. World J Gastroenterol. 2004;10: 2886-2889. (Pubitemid 39303012)
30. Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998;396:580-584. (Pubitemid 28563719)
31. Xiaoyuan C, Longbang C, Jinghua W, et al. Survivin: A potential prognostic marker and chemoradiotherapeutic target for colorectal cancer. Ir J Med Sci. 2010;179:327-335.
32. Qi G, Tuncel H, Aoki E, et al. Intracellular localization of survivin determines biological behavior in colorectal cancer. Oncol Rep. 2009;22:557-562.
33. Lee YY, Yu CP, Lin CK, et al. Expression of survivin and cortactin in colorectal adenocarcinoma: Association with clinicopathological parameters. Dis Markers. 2009;26:9-18.
34. Leonardos L, Butler LM, Hewett PJ, et al. The activity of caspase-like proteases is elevated during the development of colorectal carcinoma. Cancer Lett. 1999;143:29-35. (Pubitemid 29327186)
35. de Oca J, Azuara D, Sanchez-Santos R, et al. Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer. Int J Colorectal Dis. 2008;23:21-27. (Pubitemid 350142356)
36. Glinsky GV, Glinsky VV, Ivanova AB, et al. Apoptosis and metastasis: Increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Lett. 1997;115:185-193. (Pubitemid 27196604)